Summary & Overview
CPT 4060F: No Summary Available
CPT code 4060F is a Current Procedural Terminology performance designation for which no descriptive summary was provided in the input. As a CPT code entry, it represents a billable clinical or administrative item used in medical claims, and clarity about its clinical meaning is important for national billing consistency, claims adjudication, and quality reporting. This publication addresses the absence of a summary and provides a structured overview for clinicians, billing professionals, and payers who encounter 4060F on claims.
Key payers referenced in the national context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code entry currently contains, the available service context, and which typical stakeholders review such codes when processing claims. The report also outlines what information is missing and how that affects interpretation across payers.
The audience will learn the expected areas covered in a full code profile when available — clinical description, service type, typical site of service, common modifiers, associated taxonomies, relevant ICD-10 diagnoses, related codes, and service line — and which of those items are not present in the supplied input. This summary is intended as a national reference point for organizations that must track, document, or reconcile billing codes lacking descriptive summaries.
Billing Code Overview
CPT code 4060F — No Summary found for this code
-
Service Type: Data not available in the input.
-
Typical Site of Service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient otolaryngology or allergy clinic with recurrent nasal obstruction, chronic rhinosinusitis, or suspected sinonasal mass requiring diagnostic tissue sampling. The workflow begins with a clinical history and nasal endoscopic examination. After topical anesthesia and local infiltration as needed, the clinician performs a targeted nasal or sinus mucosal biopsy or excisional sampling using forceps or curette under endoscopic visualization. Hemostasis is achieved with topical agents or cautery. The specimen is placed in formalin and sent to pathology for histologic evaluation. Post-procedure instructions include short-term activity modification and monitoring for bleeding or infection. Typical site of service is an outpatient clinic, ambulatory surgery center, or hospital outpatient department depending on patient comorbidity and extent of procedure.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M visit is documented on the same day as the biopsy procedure |
59 | Distinct procedural service |